Moderna says US FDA refuses to review its influenza vaccine

Moderna +1.80%

Moderna

MRNA

55.97

+1.80%

- Moderna MRNA.O said on Tuesday the U.S. Food and Drug Administration will not review its approval application for its influenza vaccine.


Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via